Cargando…

Amantadine‐Induced Craniofacial Myoclonus: Distinctive Iatrogenic Dysarthria in Parkinson's Disease

BACKGROUND: Amantadine is a widely prescribed medication in Parkinson's disease (PD). A distinctive craniofacial distribution of myoclonus with speech impairment is an underrecognized iatrogenic complication in amantadine‐treated patients with PD. CASES: We report 7 patients with idiopathic PD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Iris, Armengou‐Garcia, Laura, Sasikumar, Sanskriti, Kuhlman, Greg, Fox, Susan H., Lang, Anthony E., Espay, Alberto J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2023
Materias:	Case Series with Literature Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525052/ https://www.ncbi.nlm.nih.gov/pubmed/37772280 http://dx.doi.org/10.1002/mdc3.13828

Ejemplares similares

Myoclonus Secondary to Amantadine: Case Report and Literature Review
por: Rissardo, Jamir Pitton, et al.
Publicado: (2023)

Irinotecan-Induced Transient Dysarthria: Case Series and Updated Literature Review
por: De Lisa, Mariagrazia, et al.
Publicado: (2020)

Amantadine, COVID-19 and Parkinsonism
por: Wiwanitkit, Viroj
Publicado: (2020)

Parkinson's Patients with Dyskinesia Switched from Immediate Release Amantadine to Open‐label ADS‐5102
por: Isaacson, Stuart H., et al.
Publicado: (2018)

Response to: Amantadine, COVID-19 and Parkinsonism
por: Aranda-Abreu, Gonzalo Emiliano
Publicado: (2020)

Hypokinetic Dysarthria in Parkinson’s Disease: A Narrative Review
por: Atalar, Merve Sapmaz, et al.
Publicado: (2023)

Imaging Mild Cognitive Impairment and Dementia in Parkinson's Disease
por: Sasikumar, Sanskriti, et al.
Publicado: (2020)

Amantadine-Induced Patulous Eustachian Tubes in Parkinson's Disease
por: Boyd, J. T., et al.
Publicado: (2013)

The Dysarthria Impact Profile: A Preliminary French Experience with Parkinson's Disease
por: Letanneux, Alban, et al.
Publicado: (2013)

Management of Parkinson's Disease Dysarthria: Can Artificial Intelligence Provide the Solution?
por: Kumar, Raj, et al.
Publicado: (2022)

Computerized analysis of hypomimia and hypokinetic dysarthria for improved diagnosis of Parkinson's disease
por: Skibińska, Justyna, et al.
Publicado: (2023)

Irinotecan-Induced Dysarthria
por: Dressel, Albertine J., et al.
Publicado: (2012)

HYPOTHYROIDISM PRESENTING WITH DYSARTHRIA
por: El-Shafie, Kawther T.
Publicado: (2003)

Surgical Management of Iatrogenic Pigment Dispersion Glaucoma
por: Mierlo, Camille Van, et al.
Publicado: (2015)

Amantadine for Dyskinesias in Parkinson's Disease: A Randomized Controlled Trial
por: Sawada, Hideyuki, et al.
Publicado: (2010)

An updated meta-analysis of amantadine for treating dyskinesia in Parkinson's disease
por: Kong, Min, et al.
Publicado: (2017)

Investigation of the Long-Term Effects of Amantadine Use in Parkinson’s Disease
por: Park, Sangmin, et al.
Publicado: (2023)

Abdominal wall endometriosis: A challenging iatrogenic disease()
por: Ferjaoui, Mohamed Aymen, et al.
Publicado: (2021)

Quantitative Analysis of Relationship Between Hypokinetic Dysarthria and the Freezing of Gait in Parkinson’s Disease
por: Mekyska, Jiri, et al.
Publicado: (2018)

The physical significance of acoustic parameters and its clinical significance of dysarthria in Parkinson’s disease
por: Yang, Shu, et al.
Publicado: (2020)

Characterization of Mild and Moderate Dysarthria in Parkinson’s Disease: Behavioral Measures and Neural Correlates
por: Steurer, Hanna, et al.
Publicado: (2022)

Tessier 1-13 Atypical Craniofacial Cleft
por: Gargano, Francesco, et al.
Publicado: (2015)

Pure dysarthria and dysarthria-facial paresis syndrome due to internal capsule and/or corona radiata infarction
por: Tanaka, Koji, et al.
Publicado: (2015)

Reckless Generosity, Parkinson's Disease and Dopamine: A Case Series and Literature Review
por: Amstutz, Deborah, et al.
Publicado: (2021)

Calcium Channel Blockers- Induced Iatrogenic Gingival Hyperplasia: Case Series
por: Priyadarshini, G. Agnes Golda, et al.
Publicado: (2023)

Fahr's disease presenting as Parkinson's disease along with dysphagia and dysarthria: A case report
por: Sapkota, Dilip, et al.
Publicado: (2023)

Vowel production: a potential speech biomarker for early detection of dysarthria in Parkinson’s disease
por: Roland, Virginie, et al.
Publicado: (2023)

An Uncommon Cause of Dysarthria in an Elderly Gentleman
por: Noushad, Muhammad, et al.
Publicado: (2020)

Dysarthria in children and adults with ataxia telangiectasia
por: Veenhuis, Stefanie J G, et al.
Publicado: (2021)

Communicative Participation in Dysarthria: Perspectives for Management
por: Page, Allyson D., et al.
Publicado: (2022)

Orofacial Muscle Strength across the Dysarthrias
por: Clark, Heather M., et al.
Publicado: (2022)

A 54‐year‐old with dysarthria
por: Huang, Derrick, et al.
Publicado: (2022)

Validation of the pediatric Radboud Dysarthria Assessment
por: Ruessink, Marieke, et al.
Publicado: (2022)

Impact of Oral Fast Release Amantadine on Movement Performance in Patients with Parkinson’s Disease
por: Muhlack, Siegfried, et al.
Publicado: (2010)

Neuroprotective effect of Spirulina fusiform and amantadine in the 6-OHDA induced Parkinsonism in rats
por: Chattopadhyaya, I, et al.
Publicado: (2015)

Amantadine extended release for levodopa‐induced dyskinesia in Parkinson's disease (EASED Study)
por: Pahwa, Rajesh, et al.
Publicado: (2015)

Amantadine extended-release capsules for levodopa-induced dyskinesia in patients with Parkinson’s disease
por: Sharma, Vibhash D, et al.
Publicado: (2018)

Molecular docking investigation of the amantadine binding to the enzymes upregulated or downregulated in Parkinson’s disease
por: Ionescu, Mihaela Ileana
Publicado: (2020)

Brain morphological changes in hypokinetic dysarthria of Parkinson's disease and use of machine learning to predict severity
por: Chen, Yingchuan, et al.
Publicado: (2020)

A Neuromotor to Acoustical Jaw-Tongue Projection Model With Application in Parkinson’s Disease Hypokinetic Dysarthria
por: Gómez, Andrés, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ic19v8sdsqeur4ca213vssptnk